GH Research $200 million at-the-market offering
We advised GH Research on the establishment of the at-the-market program
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
METiS TechBio HK$2.43 billion IPO
We advised METiS TechBio on its IPO and HKEX listing
Tempus AI $460 million convertible senior notes offering
We advised the representatives of the several initial purchasers on the offering
Personalis $150 million at-the-market offering
We advised the sales agents on the offering
Viridian Therapeutics $250 million convertible senior notes offering
We acted as special product counsel to the representatives of the several underwriters on the offering
Alector $125 million at-the-market offering
We advised the sales agent on the offering
Oruka Therapeutics $700 million follow-on offering
We advised Oruka on the offering
GH Research $117.5 million follow-on offering
We advised GH Research on the offering
Avalyn Pharma $300 million IPO
We advised the underwriters on the IPO
Mabwell Bioscience HK$1.2 billion IPO
We advised Mabwell on its IPO and HKEX listing